These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30746252)

  • 1. Are quality of life outcomes comparable following stereotactic radiotherapy and minimally invasive surgery for stage I lung cancer patients?
    Pompili C; Absolom K; Franks K; Velikova G
    J Thorac Dis; 2018 Dec; 10(12):7055-7063. PubMed ID: 30746252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC).
    Pompili C; Franks KN; Brunelli A; Hussain YS; Holch P; Callister ME; Robson JM; Papagiannopoulos K; Velikova G
    J Thorac Dis; 2017 Aug; 9(8):2703-2713. PubMed ID: 28932579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: A longitudinal study.
    Pompili C; Rogers Z; Absolom K; Holch P; Clayton B; Callister M; Robson J; Brunelli A; Franks K; Velikova G
    Lung Cancer; 2021 Dec; 162():71-78. PubMed ID: 34741885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis.
    Verstegen NE; Oosterhuis JW; Palma DA; Rodrigues G; Lagerwaard FJ; van der Elst A; Mollema R; van Tets WF; Warner A; Joosten JJ; Amir MI; Haasbeek CJ; Smit EF; Slotman BJ; Senan S
    Ann Oncol; 2013 Jun; 24(6):1543-8. PubMed ID: 23425947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of anxiety, depression and quality of life in medically inoperable early stage non-small cell lung cancer patients treated with stereotactic ablative radiotherapy.
    Rutkowski J; Szymanik M; Blok M; Kozaka J; Zaucha R
    Rep Pract Oncol Radiother; 2017; 22(3):217-222. PubMed ID: 28461786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?
    Bertolaccini L; Terzi A; Ricchetti F; Alongi F
    Ann Transl Med; 2015 Feb; 3(2):25. PubMed ID: 25738145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more.
    White A; Swanson SJ
    J Thorac Dis; 2016 Apr; 8(Suppl 4):S399-405. PubMed ID: 27195137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer.
    Mutsaers A; Greenspoon J; Walker-Dilks C; Swaminath A
    Radiat Oncol; 2017 Jun; 12(1):110. PubMed ID: 28662680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis.
    Paul S; Lee PC; Mao J; Isaacs AJ; Sedrakyan A
    BMJ; 2016 Jul; 354():i3570. PubMed ID: 27400862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?
    Uzel EK; Abacıoğlu U
    Balkan Med J; 2015 Jan; 32(1):8-16. PubMed ID: 25759766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of operative approach on quality of life following anatomic lung cancer resection.
    Singer ES; Kneuertz PJ; Nishimura J; D'Souza DM; Diefenderfer E; Moffatt-Bruce SD; Merritt RE
    J Thorac Dis; 2020 Nov; 12(11):6913-6919. PubMed ID: 33282394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
    Edwards JP; Datta I; Hunt JD; Stefan K; Ball CG; Dixon E; Grondin SC
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1599-606. PubMed ID: 26796110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
    Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B;
    Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.
    Li M; Yang X; Chen Y; Yang X; Dai X; Sun F; Zhang L; Zhan C; Feng M; Wang Q
    Onco Targets Ther; 2017; 10():2885-2892. PubMed ID: 28652770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
    Palma DA; Nguyen TK; Kwan K; Gaede S; Landis M; Malthaner R; Fortin D; Louie AV; Frechette E; Rodrigues GB; Yaremko B; Yu E; Dar AR; Lee TY; Gratton A; Warner A; Ward A; Inculet R
    Radiat Oncol; 2017 Jan; 12(1):30. PubMed ID: 28129789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer.
    Lagerwaard FJ; Aaronson NK; Gundy CM; Haasbeek CJ; Slotman BJ; Senan S
    J Thorac Oncol; 2012 Jul; 7(7):1148-54. PubMed ID: 22610256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.
    Boily G; Filion É; Rakovich G; Kopek N; Tremblay L; Samson B; Goulet S; Roy I;
    J Thorac Oncol; 2015 Jun; 10(6):872-82. PubMed ID: 26001140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
    Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
    Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.